Syremis Therapeutics

Series-A
syremis.com Biotech & Healthcare Tel Aviv, Israel Founded 2025 11-50
Total Funding $165M
Latest Round $165M Series-A
Last Announced Dec 18, 2025
Investors 6 Backers
Decision Makers 4 Verified

About Syremis Therapeutics

Syremis Therapeutics is developing novel medicines to make a profound impact on the treatment of mental health disorders.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters Tel Aviv, Israel
Year Founded 2025
Team Size 11-50
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website syremis.com
Domain Registered Date May 19, 2025

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

3 Events
  1. Capital Raise

    Raised $165,000,000 · Series-A

    fundraisingfox.com

  2. Milestone

    Website domain registered

    syremis.com

  3. Milestone

    Company founded

    Tel Aviv, Israel

Investors & Backers

6
Bain Capital Life Sciences
Dexcel Pharma
GV
Pictet Private Equity Investors S.A.
QVT Financial
Third Rock Ventures

Funding History

1 Round
Series-A · Dec 18, 2025

Founders & Leadership

2

Aaron Koenig

Chief Medical Officer

Work email & phone locked Unlock →

Elisabeth Kogan

Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts